MEDIASTINAL emphysema, its precursors and its sequelae have been known to clinicians for well over a century. Laënnec, 1 in his treatise on diseases of the chest, published in 1819, gave an ...
Calquence is under clinical development by AstraZeneca and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.
Tevimbra is under clinical development by BeiGene and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.